Exploratory analysis discovers key predictive factors of improved BCVA in treatment of LHON disease with lenadogene nolparvovec

Published on August 5, 2025
Better best-corrected visual acuity values and baseline thicker ganglion cell layer and retinal nerve fiber layer at ocular coherence tomography measurements were found to be the key predictive factors.
Continue reading on website
Other news

Novel Systemic Marker Identifies Diabetes Patients at High Risk of DR

August 5, 2025
A new study found that, compared with insulin resistance, parameters indicative of β-cell function—specifically, postprandial C-peptide to glucose ratio (PCGR)—were more closely related to DR independent of diabetes duration than HbA1c or other confounding factors. This chart from the study show the AUC curves for PCGR (red line) vs. HbA1c (blue line). Monitoring this systemic marker could help id

Alcon Agrees to Acquire STAAR Surgical, Deal Estimated at $1.5 Billion

August 5, 2025
GENEVA and LAKE FOREST, Calif.—Global eyecare company Alcon (SIX/NYSE: ALC) and STAAR Surgical Company (NASDAQ: STAA), a leading developer of phakic intraocular lenses with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, announced this morning that the companies have entered into a definitive merger agreement in which Alcon intends to acquire STAAR. The transaction r